首页> 外文期刊>Acta Virologica: International Journal >Creutzfeldt-Jakob disease with E200K mutation in Slovakia: Characterization and development
【24h】

Creutzfeldt-Jakob disease with E200K mutation in Slovakia: Characterization and development

机译:斯洛伐克具有E200K突变的克雅氏病:表征和发展

获取原文
获取原文并翻译 | 示例
       

摘要

Creutzfeldt-Jakob disease (CJD), the most important human prion disease, occurs in sporadic, iatrogenic and familial form. Except Slovakia and Israel, the recorded familial cases have never exceeded 10-15%. In the Slovak CJD group 95 out of 136 CJD cases (74.2%) carried a CJD-specific mutation in the prion protein gene (PRNP) at codon 200 (mutation E200K). All CJD(E200K) patients carried a heterozygous E200K mutation within the alelle with methionine at codon 129. No more than 53.7% were typical familial cases. The penetrance of the E200K mutation in 1975-2000 was 59.5%. The distribution of codon 129 polymorphism showed 78.6% of methionine-homozygous and 21.4% of methionine/valine-heterozygous patients. Genetic analysis performed on 278 CJD patient relatives demonstrated the E200K mutation in 97 (34.8%) of healthy relatives tested. The E200K mutation carriers were methionine-homozygous in 64% and methionine/valine-heterozygous in 36%. The relatives without the mutation showed a 54.9% methionine homozygosity, 10.4% valine homozygosity and 34.7% methionine/valine heterozygosity. Analysis of the E200K carriers provided evidence that the methionine homozygosity is a CJD risk factor, more efficient in CJD patients than in asymptomatic relatives. Th influence of both the E200K mutation and methionine homozygosity at codon 129 was evident in the duration of the clinical stage of CJD and in the immunoreactivity pattern of PrP resistant to proteases (PrPres). In the CJD(E200K) methionine-homozygous patients the mean duration of the disease was significantly shorter (3.7 +/- 2.0 months) than in the methionine/valine-heterozygous patients (7.84 +/- 7.3 months). Comparison of the PrPres positivity in the cerebellum of familial and sporadic CID using specific polyclonal and monoclonal antibodies (MAbs) to PrP showed less conspicuous immune reaction in CJD(E200K) cases. Methionine-homozygous CJD patients were characteristic mainly by synaptic pattern of staining, while methionine/valine-heterozygous patients by PrPres granules and plaque-like structures. Most of numerous plaque-like PrPres deposits were found in sporadic valine/valine-homozygous cases. Potential professional risk was excluded in health facility workers. The percentage of professions related to farming was significantly higher in CJD(E200K) (48%) and sporadic CJD (44%) cases as compared to the employed population (9%).
机译:Creutzfeldt-Jakob病(CJD)是最重要的人类病毒病,以散发,医源性和家族性形式发生。除斯洛伐克和以色列外,记录的家族病例从未超过10-15%。在斯洛伐克CJD组中,136例CJD病例中有95例(74.2%)在200密码子的carried病毒蛋白基因(PRNP)中携带了CJD特异性突变(突变E200K)。所有CJD(E200K)患者在小肠内均携带杂合E200K突变,其中甲硫氨酸的密码子为129。典型家族病例不超过53.7%。 1975-2000年E200K突变的渗透率为59.5%。 129位密码子的多态性分布显示,甲硫氨酸-纯合子患者占78.6%,蛋氨酸/缬氨酸-杂合子患者占21.4%。对278名CJD患者亲属进行的遗传分析表明,有97名(34.8%)健康亲戚中有E200K突变。 E200K突变携带者为64%的蛋氨酸-纯合子和36%的蛋氨酸/缬氨酸-杂合子。没有突变的亲戚显示出54.9%的蛋氨酸纯合度,10.4%的缬氨酸纯合度和34.7%的蛋氨酸/缬氨酸杂合度。对E200K携带者的分析提供了证据,证明甲硫氨酸纯合性是CJD的危险因素,在CJD患者中比无症状的亲属更有效。 E200K突变和第129位密码子的蛋氨酸纯合性的影响在CJD临床阶段的持续时间和PrP对蛋白酶(PrPres)的免疫反应模式中均很明显。在CJD(E200K)蛋氨酸-纯合子患者中,平均病程(3.7 +/- 2.0个月)明显短于蛋氨酸/缬氨酸-杂合子患者(7.84 +/- 7.3个月)。使用针对PrP的特异性多克隆抗体和单克隆抗体(MAb)比较家族性和散发性CID小脑中PrPres阳性,在CJD(E200K)病例中免疫反应较不明显。蛋氨酸-纯合CJD患者的特征主要在于突触的染色模式,蛋氨酸/缬氨酸-杂合体患者的特征在于PrPres颗粒和斑块状结构。在散发的缬氨酸/缬氨酸-纯合子病例中发现了许多斑块状的PrPres沉积物。卫生设施工作人员中排除了潜在的专业风险。与就业人口(9%)相比,CJD(E200K)和散发性CJD病例中与农业相关的职业百分比显着更高(48%)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号